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This study aimed to assess the antibacterial and antibiotic potentiating property of Vangueria mada-
gascariensis (VM) (fruit and leaf extracts) against 10 clinical isolates. A microdilution broth susceptibility
assay for bacteria was used for the determination of the minimum inhibitory concentration (MIC) and
associated with antibiotics to evaluate any synergistic effect. VM extracts were found to potentiate the
activity of 3 conventional antibiotics. Chloramphenicol and Ciproﬂoxacin showed no activity against
Acinetobacter spp. but when mixed with VM (in a ratio of 50% VM extracts: 30% antibiotic), showed
potentiating effect. The methanolic fruit extract at lower concentration of Chloramphenicol (30%) gave
better synergistic effect (MIC ¼ 3.75 mg/mL) as compared to 50% (MIC ¼ 12.5 mg/mL). With Gentamicin,
no activity was detected with leaf decoction but other extracts (methanolic leaf/fruit extract and fruit
decoction) showed enhancement (MIC- 0.47, 7.5 and 15 mg/mL respectively). Interestingly, Chloram-
phenicol showed no activity against MRSA, but when mixed with VM, produced low MICs (<0.39
e0.78 mg/mL with 50% antibiotic and from <0.47 to 0.94 mg/mL with 30% antibiotic). Combining
Gentamicin with VM extracts showed an enhancement in the potentiating activity against MRSA. In
conclusion, the observed antimicrobial property of VM tend to suggest a promising alternative and
complementary strategy to manage bacterial infections and hence can open new avenues for further
research using traditional medicinal food plant.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
It is common knowledge that the last few decades have expe-
rienced a growing public health challenge in relation to the control
and management of infectious diseases and microbial resistance to
existing therapies.1 Indeed, recent studies by the World Health
Organisation (WHO) tend to conﬁrm that new resistance mecha-
nisms have emerged, making the latest generation of antibiotics
virtually ineffective.2 Studies have also emphasised on the impact
of antimicrobial resistance on various outcomes, including mor-
tality, morbidity, cost and lengthy hospitalisation.3,4 Resistance of
pathogens against conventional antibiotics has compelled users to
probe for substitutes of conventional antimicrobials.5 To this effect,. Mahomoodally).
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).traditionally used medicinal herbs and food plants have attracted
much interest in the scientiﬁc community as potential alternative
antimicrobial agents. Indeed, the nutraceutical value and functional
importance of food plants have received much attention as sup-
ported by the growing number of publication during the last past
decades emphasizing on the property of food plants for their
diversiﬁed health beneﬁts and potential clinical applications.6,7
Health experts are now recognizing that a synergism of drug
therapy and nutrition might give optimum results in the ﬁght
against existing and emerging diseases. Indeed, theWHO estimates
that 70%e80% of the world population relies on traditional rem-
edies including the use of medicinal food plants as primary health
care to manage and treat various diseases.8
Vangueria madagascariensis (VM) J.F. Gmelin. (Rubiaceae) is a
native medicinal food plant from Africa that naturally grows along
the river banks of forests and volcanic ash soils throughout Africa
and Asia. This perennial food plant is in common use in thersity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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Trinidad.9,10 The genus ‘Vangueria’ is derived from the Madagascan
vernacular name ‘voa-vanguier’. Other common local vernacular
names include ‘Voavanga’ and ‘Vavandrika’ in Madagascar;
‘Vavang’ and ‘Vavangue’ in Mauritius, Madagascar and Seychelles as
well as ‘mviru’ or ‘muiru’ in Swahili. Common English names of VM
are Spanish-tamarind, or tamarind-of-the-Indies.11e13
Vangueria has received scientiﬁc attention for its extensive
ethnomedicinal applications worldwide. Generally cultivated for its
sweet-sour fruits, this plant has also brought signiﬁcant contribu-
tion in the African Materia Medica for its antimicrobial properties
since time immemorial.7 Preliminary in vitro study showed that VM
possesses antimicrobial potential against Staphylococcus aureus
(ATCC 25923) and Escherichia coli (ATCC 25922). In vitro data
revealed the presence of a number of bio-constituents with pluri-
potential mechanism of action which might be responsible for its
medicinal virtues.13 In the light of the above, the present study was
designed to further investigate into the antibacterial and antibiotic-
potentiating property of VM against clinical pathogenic isolates. It
is anticipated that the present work might establish important
baseline data on the antibacterial property of VM as a traditional
food which can open new avenues for research and bio-product
development to manage infectious diseases.
2. Materials and methods
2.1. Collection and preparation of plant samples
Fresh leaves and ripe fruits of VM were collected from the
northern parts of Mauritius and authenticated by a local botanist.
Samples were thoroughly washed under running tap water, fol-
lowed by distilled water and patted dry on the same day of
collection to remove any undesired substances and kept at 4 C
until further processing.
Fresh leaves were cut and air dried under shade till a constant
mass was obtained. Direct sunlight and temperatures above 40 C
were avoided during drying. The dried leaves were grinded in a
clean electrical food grinder to a ﬁne homogenized powder and
stored in dark air-tight containers at 4 C.
The ripe fruits were cut into small pieces using sterile scalpel.
The seeds were discarded and the pericarp pieces were stored
at 18 C for 48 h until they became brittle. Then the pericarp was
lyophilized (Modulo Edwards: F101-01-000) for 24 h. The samples
were then homogenized to a ﬁne powder using an electrical food
grinder and stored in dark air-tight containers at 18 C to be used
later.
Methanol (500 mL of 70%) was added to 50 g of leaves, mixed
and covered with aluminium foil. The mixture was left for 24 h at
room temperature with frequent mixing and then ﬁltered. The
ﬁltrate was subjected to Rotary Vacuum Evaporator e in vacuo
(Stuart RE100). These steps were repeated multiple times for
exhaustive maceration. The resultant sample was then lyophilized
and the sticky material was stored in dark air-tight containers
at 18 C to be used later. Same procedure was used for the ripe
fruit parts.
The most common method of using VM locally is in aqueous
form, i.e. by boiling of the fruits and leaves.14 Hence, the aqueous
crude extract of VM was also prepared and evaluated for possible
biological properties. The already processed fruit and leaves were
subjected to reconstituted-boiling for few hours (200 mL sterile
distilled water was added to 50 g of leaves powder). The sample
powder was mixed and boiled until reduced to 1/4 of the original
volume. After cooling, the extract obtained was ﬁltered through
sterile muslin cloth for removal of large unwanted material and
then through sterile Whatman (Number 1) ﬁlter paper. The ﬁltratewas subjected to Rotary Vacuum Evaporator e in vacuo (Stuart
RE100). The resultant sample was again lyophilized and stored in
dark air-tight containers at18 C to be used later. Same procedure
was adopted to process the fruits. The percentage yield was
calculated.
2.2. Microdilution broth susceptibility assay
The microorganisms used in the present investigation included
human pathogenic clinical bacterial isolates (Acinetobacter spp., E.
coli, Enterococcus faecalis, Klebsiella spp., Proteus spp., Pseudomonas
aeruginosa, S. aureus, Streptococcus group A, Streptococcus group B,
and Methicillin-resistant S. aureus [MRSA]) obtained from Central
Laboratory, Victoria Hospital, Candos, Mauritius.
A microdilution broth susceptibility assay for bacteria was used,
as described previously for the determination of the minimum
inhibitory concentration (MIC) in 96-well microplates with INT (2-
(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride)
colourimetric assay with some modiﬁcations.15e17 The procedure
involves the transfer of 1 mL of fresh inoculums of microorganisms
aseptically to 50 mL of peptone broth. These yielded 106 CFU/mL.
Sterile peptone broth (100 mL) was then transferred aseptically into
each well. Respective stock solutions (100 mL) and control antibi-
otics (Chloramphenicol and Gentamicin at 2 mg/mL) were trans-
ferred to each of the ﬁrst 3 wells of the ﬁrst row of the 96-microtitre
plate. Double dilution was carried out from the ﬁrst to last row and
the last remaining was discarded. Inoculum (100 mL) was added to
each respective well. The plates with bacteria were then incubated
for 24 h at 37 ± 1 C. After incubation, 40 ml of INT at concentration
0.2 mg/mL was added to each well. The plates were further incu-
bated for 30 min at 37 C. Viable bacteria reduce the yellow dye to
pink. Well with no pinkish red colour was taken to be the actual
MIC.
2.3. Antibiotic potentiating assay
Extracts showing signiﬁcant bacterial activities as compared to
the positive control in the previous microdilution broth suscepti-
bility assaywere associated with conventional antibiotics in view of
evaluating any possible synergistic effect.20 106 CFU/mL of micro-
organisms as described in the microbroth technique was used in
the antibiotic potentiating assay. Sterile peptone (100 mL) broth was
then transferred aseptically into each well. A ﬁnal combination
70 mL of the respective stock solutions and 30 mL of antibiotics
(Chloramphenicol, Ciproﬂoxacin and Gentamicin at concentration
of 2 mg/mL) were transferred to each of the ﬁrst 3 wells of the ﬁrst
row of the 96-microtitre plate. In the second 3 wells, 50 mL of the
respective stock solutions and 50 mL of antibiotics were added. The
third and the fourth 3 wells were used as control and blank
respectively. Double dilution was carried out from the ﬁrst to last
row. Inoculum (100 mL) was added to each respective well. The
plates were then incubated for 24 h at 37 ± 1 C. After incubation,
40 ml of INTat concentration 0.2mg/mLwas added to eachwell. The
plates were further incubated for 30 min at 37 C. A colour change
from yellow to pink indicates bacterial growth.
3. Results and discussion
3.1. Antimicrobial activity
Table 1 shows results obtained for the antimicrobial property of
VM extracts against the tested clinical isolates. The MIC recorded
ranged between <0.10 to 6.25 mg/mL. MIC <0.20 mg/mL was
recorded against E. faecalis, Streptococcus group A and B using VM
methanolic leaf extract. The fruit decoction extract showed
Table 1
MIC of VM extracts using the microbroth technique.
Test microorganisms MIC (mg/mL)a
Controls VM extracts
Gentamicinb Chloramphenicol Methanol Decoction
Leaf Fruit Leaf Fruit
Acinetobacter spp. 0.10 e e 3.13 e 1.56
Escherichia coli 0.03 <0.01 3.13 6.25 3.13 0.78
Enterococcus faecalis 0.05 <0.01 <0.20 3.13 3.13 3.13
Klebsiella spp. e <0.01 3.13 12.5 3.13 12.5
Proteus spp. e 0.10 3.13 3.13 6.25 1.56
Staphylococcus aureus 0.05 e 3.13 3.13 3.13 1.56
Streptococcus group A <0.01 <0.01 <0.20 0.78 0.78 <0.10
Streptococcus group B 0.05 e <0.20 1.56 0.78 0.78
Methicillin-resistant Staphylococcus aureus (MRSA) 0.05 e 6.25 3.13 6.25 3.13
a No. of replicates (n ¼ 3) for each sample. (e), No activity detected.
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group A (both MICs of <0.10 mg/mL). The MIC recorded was
6.25 mg/mL against E. coli using methanolic fruit extract. Interest-
ingly, VM extracts (both fruit and leaf) showed activity against
MRSA and being more potent that the antibiotic Chloramphenicol.
Differences in antimicrobial activity of the different parts of VM
against the clinical isolates are related to differences in their
bioactive phytochemical composition. Available reports tend to
show that alkaloids and ﬂavonoids are the responsible compounds
for the antimicrobial activities in higher plants. Moreover, it was
also claimed that secondary metabolites such as tannins and other
compounds of phenolic nature are classiﬁed as active antimicrobial
compounds.18 Interestingly, we previously reported the pre-
liminary phytochemicals screening of VM which showed the
presence of phenols and ﬂavonoids.13 Therefore, the presence of
these phytochemicals could to some extent justify the observed
antimicrobial activities in the current study. Moreover, as the cur-
rent antimicrobial study was done using the aqueous preparation
as locally prescribed by the traditional healers, therefore these re-
sults would tend to support the way people use VM as a herbal
remedy.Table 2
Potentiating activity using 50% antibiotics with 50% VM extracts.
B MIC (mg/mL)
Control Chloramphenicol (CL) C
CL CIP GEN Methanola Decoctiona M
1 e 100 100 1562.50 (3125)
[6.25 (12.5)]
6250 (<48.83)
[25 (<0.39)]
<
[
2 <0.78 25 25 (1562.50)
[(6.25)]
781.25 (6250)
[3.13 (50)]
1
[
3 <0.78 3.13 50 12,500 (6250)
[50 (25)]
3125 (3125)
[12.5 (25)]
<
[
4 <0.78 25 e <97.66 (12500)
[<0.39 (50)]
3125 (6250)
[12.5 (50)]
6
[
5 100 e e 6250 (12500)
[25 (50)]
12500 (3125)
[50 (25)]
7
[
6 e 50 50 <97.66 (6250)
[<0.39 (25)]
1562.5 (6250)
[6.25 (50)]
<
[
7 <0.78 0.78 <0.78 <97.66 (781.25)
[<0.39 (3.13)]
781.25 (3125)
[3.13 (25)]
<
[
8 e 6.25 50 <97.66 (1562.50)
[<0.39 (6.25)]
781.25 (<48.83)
[3.13 (<0.39)]
7
[
9 e 0.78 50 <97.66 (195.3)
[<0.39 (0.78)]
195.30 (97.66)
[0.78 (0.78)]
1
[
No. of replicates (n ¼ 3) for each sample.
a Concentration of; leaf extract (fruit extract) [antibiotic in leaf extract (antibiotic in fr
faecalis; (4) Klebsiella spp.; (5) Proteus spp.; (6) Staphylococcus aureus; (7) Streptococcus
(MRSA): (e), No activity detected.3.2. Potentiating activity using antibiotics
The potentiating activity of VM (mixing 3 commonly utilised
antibiotics with some pathogenic clinical isolates) was investigated
by mixing VM extracts with respective antibiotics (Ciproﬂoxacin,
Chloramphenicol and Gentamicin) at speciﬁc concentrations.
Results recorded following addition of 50% antibiotics with 50%
VM extracts and using 30% antibiotics with 70% VM extracts are
summarised in Tables 2 and 3. Various activities have been recor-
ded which enhanced the antimicrobial potentiating activity of VM.
It can be deduced from the results that mixing of antibiotics and VM
extracts resulted in signiﬁcant antibacterial properties by reducing
the MICs. Indeed, an overall enhancement of the antibiotics in
combination with VM extracts was recorded but some reduction in
efﬁciency was also noted.
It was found that Chloramphenicol and Ciproﬂoxacin showed no
activity against Acinetobacter spp. but when mixed with extracts of
VM (in a ratio of 50% VM and 30% antibiotic), potentiating activity
was recorded. It can be noticed that for methanolic fruit extract,
lower concentration of Chloramphenicol (30%) gave more syner-
gistic effect (MIC 3.75 mg/mL) as compared to 50% (MIC 12.5 mg/mL).iproﬂoxacin (CIP) Gentamicin (GEN)
ethanola Decoctiona Methanola Decoctiona
97.66 (<97.66)
<0.39 (<0.39)]
<97.66 (390.63)
[<0.39 (3.13)]
1562.5 (6250)
[6.25 (25)]
(6250)
[(50)]
562.5 (<97.66)
6.25 (<0.39)]
<97.66 (<48.83)
[<0.39 (<0.39)]
<97.66(e)
[<0.39(e)]
(<48.83)
[(<0.39)]
97.66 (1562.5)
<0.39 (6.25)]
6250 (6250)
[25 (50)]
<97.66(e)
[<0.39(e)]
3125 (6250)
[12.5 (50)]
250 (12500)
25 (50)]
3130 (6250)
[12.5 (50)]
12500(e)
[50(e)]
12500 (e)
[50(e)]
81.25 (3125)
3.13 (12.5)]
<97.66 (6250)
[<0.39 (50)]
(e)
[(e)]
(6250)
[(50)]
97.66 (6250)
<0.39 (25)]
<97.66 (6250)
[<0.39 (50)]
<97.66(e)
[<0.39(e)]
3125 (6250)
[12.5 (50)]
97.66 (<97.66)
<0.39 (<0.39)]
<97.66 (1562.5)
[<0.39 (12.5)]
<97.66 (781.25)
[<0.39 (3.13)]
<97.66 (781.25)
[<0.39 (6.25)]
81.25 (781.25)
3.13 (3.13)]
6250 (390.63)
[25 (3.13)]
<97.66 (3125)
[<0.39 (12.5)]
1562.5 (3125)
[6.25 (25)]
562.50 (6250)
6.25 (25)]
(3125)
[(25)]
<97.66(e)
[<0.39(e)]
<97.66 (<48.83)
[<0.39 (<0.39)]
uit extract)]. B; Bacteria; (1) Acinetobacter spp.; (2) Escherichia coli; (3) Enterococcus
group A; (8) Streptococcus group B; (9) Methicillin-resistant Staphylococcus aureus
Table 3
Potentiating activity using 30% antibiotics with 70% VM extracts.
B MIC (mg/mL)
Control Chloramphenicol (CL) Ciproﬂoxacin (CIP) Gentamicin (GEN)
CL CIP GEN Methanola Decoctiona Methanola Decoctiona Methanola Decoctiona
1 e 100 100 17,500 (2187.5)
[15 (3.75)]
17500 (68.36)
[30 (0.23)]
<136.72 (4375)
[<0.23 (7.5)]
<136.72 (4375)
[<0.23 (15)]
273.44 (4375)
[0.47 (7.5)]
(4375)
[(15)]
2 <0.78 25 25 8750 (1093.75)
[15 (1.86)]
546.88 (1093.75)
[0.94 (3.75)]
<136.72 (<136.72)
[<0.23 (<0.23)]
<136.72 (<68.36)
[<0.23 (<0.23)]
<136.72(e)
[<0.23(e)]
(<68.36)
[(<0.23)]
3 <0.78 3.13 50 1093.75 (2187.5)
[1.86 (3.75)]
2187.5 (2187.5)
[3.75 (7.5)]
<136.72 (2185)
[<0.23 (3.75)]
4375 (4375)
[7.5 (15)]
<136.72 (4375)
[<0.23 (7.5)]
546.88 (2187.5)
[0.94 (7.5)]
4 <0.78 25 e 273.44 (2187.5)
[0.47 (3.75)]
1093.75 (4375)
[1.86 (15)]
1093.75 (4375)
[1.86 (7.5)]
1093.75 (2187.5)
[1.86 (7.5)]
2187.5()
[3.75()]
2187.5()
[3.75()]
5 100 e e 1093.75 (4375)
[1.86 (7.5)]
4375 (2187.5)
[7.5 (7.5)]
273.44 (8750)
[0.47 (15)]
<136.72 (1093.75)
[<0.23 (3.75)]
(e)
[(e)]
(2187.5)
[(7.5)]
6 e 50 50 <136.72 (2187.5)
[<0.23 (3.75)]
1093.75 (2187.5)
[1.86 (7.5)]
<136.72 (4375)
[<0.23 (7.5)]
<136.72 (1093.75)
[<0.23 (3.75)]
<136.72 (4375)
[<0.23 (7.5)]
2187.5 (4380)
[3.75 (15)]
7 <0.78 0.78 <0.78 <136.72 (273.44)
[<0.23 (0.47)]
273.44 (546.88)
[0.47 (1.86)]
<136.72 (<136.72)
[<0.23 (<0.23)]
<136.72 (273.44)
[<0.23 (0.94)]
<136.72 (273.44)
[<0.23 (0.47)]
<136.72 (273.44)
[<0.23 (0.94)]
8 e 6.25 50 <136.72 (546.88)
[<0.23 (0.94)]
273.44 (68.36)
[0.47 (0.23)]
<136.72 (273.44)
[<0.23 (0.47)]
4375 (1093.75)
[7.5 (3.75)]
<136.72 (1093.75)
[<0.23 (1.86)]
1093.75 (1093.75)
[1.86 (3.75)]
9 e 0.78 50 273.44 (546.88)
[0.47 (0.94)]
546.88 (273.44)
[0.94 (0.94)]
273.44 (2187.5)
[0.47 (3.75)]
(546.88)
[(1.86)]
<136.72(e)
[<0.23(e)]
<136.72 (<68.36)
[<0.23 (<0.23)]
No. of replicates (n ¼ 3) for each sample.
a Concentration of; leaf extract (fruit extract) [antibiotic in leaf extract (antibiotic in fruit extract)]. B; Bacteria; (1) Acinetobacter spp.; (2) Escherichia coli; (3) Enterococcus
faecalis; (4) Klebsiella spp.; (5) Proteus spp.; (6) Staphylococcus aureus; (7) Streptococcus group A; (8) Streptococcus group B; (9) Methicillin-resistant Staphylococcus aureus
(MRSA): (e), No activity detected.
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concentration lowered the MIC to <0.23 mg/mL as compared to that
of 50% (<0.39 mg/mL). With Gentamicin, no activity was detected
with leaf decoction but other extracts (leaf/fruit methanolic ex-
tracts and fruit decoction) showed antimicrobial enhancement
(MIC of 0.47 mg/mL, 7.5 mg/mL and 15 mg/mL respectively) at 30%
antibiotic.
Chloramphenicol showed a decrease or no activity against E.
coli. With Ciproﬂoxacin, there was an increase in potentiating ac-
tivity of the latter from 50% (<0.39 mg/mL) to 30% (<0.23 mg/mL)
when combined with VM extracts. At 50% and 30% Gentamicin, no
activity was detected with methanolic fruit extract and leaf
decoction but an increase in potentiating activity was observed
with methanolic leaf extract and fruit decoction from <0.39 mg/mL
to <0.23 mg/mL.
Chloramphenicol at both 50% and 30% concentration showed a
decrease in activity against E. faecalis (i.e. an increase in MIC value)
as compared to the control. Potentiating activity was depicted in
methanolic leaf extract in 50% (<0.39 mg/mL) and 30% (<0.23 mg/
mL) concentrations with Ciproﬂoxacin. All extracts were found to
potentiate the antimicrobial activity except fruit decoction at 50%
Gentamicin.
Chloramphenicol at 50% concentration showed a potentiating
activity of <0.39 mg/mL against Klebsiella spp. Other extracts were
found to decrease the activity as compared to the control. Using 50%
Ciproﬂoxacin and Gentamicin, potentiating activity was observed
for the leaf decoction only. The other extract either decreased the
MIC level or remained unchanged. In the 70% antibiotic (Cipro-
ﬂoxacin and Gentamicin) assay, a signiﬁcant potentiating activity
was recorded with the exception of methanolic fruit extract and
fruit decoction.
Potentiating activity was recorded against Proteus spp. using any
3 antibiotics and either VM decoction or methanolic extracts with
the only exception of methanolic leaf/fruit and leaf decoction
combined with Gentamicin. Using 50% Gentamicin and VM ex-
tracts, antibacterial activity against S. aureus was enhanced with
the exception of fruit decoction combined with Ciproﬂoxacin and
Gentamicin which showed no change. Using the 30% antibioticswith VM extracts, potentiating activities were observed and
showed that increasing the concentration of VM greatly enhanced
the antimicrobial activities.
For Streptococcus group A, potentiating activity was obvious
using Chloramphenicol with both 50% (<0.39 mg/mL) and 30%
(<0.23 mg/mL) antibiotics with methanolic leaf extract. It was also
noted that the use of less antibiotic and more VM further enhanced
the antibacterial activity. Using Ciproﬂoxacin with methanolic leaf/
fruit extract and leaf decoction potentiated to <0.39 mg/mL and
<0.23 mg/mL at 50% and 30% antibiotic respectively. Furthermore,
with Gentamicin, methanolic leaf extract and leaf decoction
potentiated the activity of the antibiotic which was lower than its
original MIC (<0.39 mg/mL with 50% antibiotic and <0.23 mg/mL
with 30% antibiotic).
Chloramphenicol was not active against Streptococcus group B.
Using both 50% and 30% chloramphenicol solutions with meth-
anolic leaf extract showed potentiating activity (ranging from
<0.39 mg/mL to 6.25 mg/mL with 50% antibiotic and from <0.23 mg/
mL to 0.94 mg/mL with 30% antibiotic). For Ciproﬂoxacin, potenti-
ating activity was seen in all extracts except for leaf decoction in
both 50% and 30% antibiotics. Gentamicin together with VM ex-
tracts showed values ranging from <0.39 mg/mL to 25 mg/mL with
50% antibiotic and from <0.23 mg/mL to 3.75 mg/mL with 30%
antibiotic.
Chloramphenicol showed no activity against MRSA, but when
mixed with extracts of VM, produced lowMIC results ranging from
<0.39 mg/mL to 0.78 mg/mL with 50% antibiotic and from <0.47 mg/
mL to 0.94 mg/mL with 30% antibiotic. Mixing Ciproﬂoxacin with
VM extracts showed considerable increase in MIC (greater than the
control value e 0.78 mg/mL) in both 50% and 30% antibiotics.
Combining Gentamicin with VM extracts showed a boost in the
potentiating activity against MRSA. The values (<0.39 mg/mL and
<0.23 mg/mL with 50% and 30% antibiotic respectively) showed
signiﬁcant enhancement as compared to pure antibiotic (50 mg/
mL), with the exception of methanolic fruit extract.
The antibacterial mechanism of action of phytochemicals such
as phenols and ﬂavonoids, which are themain components of VM is
not fully understood. However, it is assumed that membrane
M.F. Mahomoodally, D. Schajeed / Journal of Traditional and Complementary Medicine 6 (2016) 399e403 403perturbation by these lipophilic components could be involved as
part of the observed antibacterial action. This could be partly due to
a hydrophobic nature of some phytochemicals from VM extracts.
Interestingly, it has already been reported that the extract from
plants can also act by improving the penetration of antibiotics in
cells via membrane alteration.19,20 Also, these phytochemicals can
interact with the double lipid layer of the cellular membrane and
affect the respiratory chain and energy production. It may also in-
crease the permeability to antibiotics leading to the suspension of
vital cellular activity or interfering with enzymatic activity.21
4. Conclusion
In conclusion, VM leaf and fruit extracts showed potent anti-
bacterial and antibiotic potentiating activity against tested antibi-
otics in vitro. The observed antimicrobial property and antibiotic
potentiating activity of VM tend to suggest a promising alternative
and complementary strategy to manage bacterial infections and
hence can open new avenues for further research using traditional
medicinal food plant. The current study also tend to advocate the
need for continuing screening for antimicrobial agents from local
medicinal food plants of Mauritius and results of this study can be
cited as evidence for antimicrobial property and antibiotic poten-
tiating activity of VM. However, the exact mechanism of antibac-
terial effects of VM needs to be further examined for potential
health uses and toxicological studies need to be carried out to
evaluate its safety.
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